The short version of Semax fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-07-26. Anything still debated is marked as such rather than presented as settled.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It corresponds to the ACTH(4-7) fragment extended at the C-terminus by a Pro-Gly-Pro tripeptide, an addition intended to slow enzymatic breakdown. The molecular formula is C37H51N9O10S and the molecular mass is approximately 814 daltons. In the literature it is often described as an ACTH(4-10) analog, although that label reflects a naming convention as much as a precise structural relationship. The compound was developed in Russia and remains most closely associated with that research tradition.
Laboratory descriptions of the material are consistent across suppliers. It appears as a white to off-white lyophilized powder that dissolves readily in water and in polar organic solvents such as dimethyl sulfoxide. Aqueous solutions are clear and colorless at low concentrations. Because the peptide contains methionine, oxidation at the sulfur atom is a recognized degradation pathway, and handling notes usually call for protected, desiccated storage. Reported purity for research-grade lots is generally above 95 percent as measured by reversed-phase high-performance liquid chromatography.
The compound is registered in Russia as a pharmaceutical product, most commonly formulated as a nasal solution, and has been used in that setting since the 1990s. Outside that jurisdiction it is generally handled as a research chemical rather than an approved medicine. Regulatory status therefore differs sharply between countries, and material sold internationally may not correspond to the Russian pharmaceutical formulation. Documentation with commercial samples is typically limited to a certificate of analysis covering purity and identity, not clinical status or local legal classification.
Laboratory work points toward modulation of neurotrophic signaling, particularly expression of brain-derived neurotrophic factor and nerve growth factor in hippocampal tissue. Studies also describe effects on monoamine turnover, inflammatory mediators, and oxidative markers. These observations come mainly from animal models and cultured cells, so the causal chain in humans is not firmly established. Whether the reported molecular changes translate into measurable clinical benefit is an open question. Reviews generally present the mechanism as plausible rather than demonstrated.
Clinical evidence consists largely of small trials with modest sample sizes, often without independent replication. Reported endpoints include cognitive scores, recovery after stroke, and visual function, but study designs vary widely and few trials meet contemporary reporting standards. Systematic reviewers have noted a high risk of bias in several of these reports. No large multicenter trial conducted outside Russia has been published. The compound is therefore best described as investigational in most jurisdictions, with its clinical role still unresolved.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Its chain combines the first seven residues of corticotropin with a C-terminal proline-glycine-proline extension, a modification intended to slow enzymatic breakdown. The free peptide has a molecular mass near 813.9 daltons. It belongs to the class of ACTH-derived fragments studied for central nervous system activity rather than for adrenal steroid stimulation. This structural relationship to a natural hormone fragment is the usual starting point for describing the compound in the literature.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C37H51N9O10S | Contains one methionine sulfur atom |
| Molecular mass | Approximately 814 Da | Consistent with a seven-residue peptide |
| Appearance | White to off-white powder | Typical lyophilized form |
| Solubility | Freely soluble in water | Also soluble in dimethyl sulfoxide |
| Typical storage | -20 °C, desiccated | Limits methionine oxidation |
Terminology around the compound varies by source. It appears in catalogues and papers as Semax, as the heptapeptide ACTH(4-7)-Pro-Gly-Pro, and under various alphanumeric laboratory codes used by individual suppliers. These names refer to the same sequence but may imply different salt forms, purity grades, or counter-ions. Peptide databases usually list the free base mass, while product descriptions sometimes report acetate or trifluoroacetate salts with a different formula weight. Because naming conventions for research peptides are not standardised across vendors, checking the declared sequence and measured mass is more reliable than relying on a trade name alone.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Its design combines the ACTH(4-7) core fragment with a C-terminal Pro-Gly-Pro extension, a modification intended to improve stability and prolong activity. The molecule is hydrophilic, carries no lipid chains or glycosylation, and has a theoretical mass just over 810 daltons in its free form. All seven residues are proteinogenic amino acids, so no non-natural building blocks appear in the backbone. A free N-terminal methionine and C-terminal proline define the unmodified parent peptide.
The compound was developed during the 1980s at the Institute of Molecular Genetics in Moscow as part of research on fragments of adrenocorticotropic hormone. Early work examined short ACTH-derived sequences that retained neurotrophic effects while lacking the endocrine activity of the full hormone. Semax entered clinical use in Russia during the 1990s, where it received registration for several neurological indications. Outside that region it remained primarily a laboratory research material rather than an approved therapeutic. English-language literature on it grew more slowly and frequently cited the original Russian studies.
Published research on this peptide originates mainly from Russian laboratories, and the wider international literature is comparatively thin. Studies have used rodent models of stroke, hypoxia, and memory tasks, with a smaller number of human trials reported. Reported outcomes include changes in attention and memory measures, along with effects on neurotrophic factor expression in some experiments. Small sample sizes, inconsistent dosing protocols, and limited independent replication are widely noted limitations, so the strength of the clinical evidence remains an open question.
Semax is a synthetic heptapeptide whose sequence is Met-Glu-His-Phe-Pro-Gly-Pro. The first four residues correspond to the ACTH(4-10) fragment, while the terminal Pro-Gly-Pro extension was added to improve metabolic stability. Its molecular formula is C37H51N9O10S and its monoisotopic mass is approximately 813.9 Da. The compound is classified as a peptide research chemical and as a registered pharmaceutical product in Russia, but it does not hold marketing approval in the European Union or the United States. Naming conventions vary across supplier catalogs.
These cytosolic formyltransferase produce fMet-tRNAi, which can be used by cytosolic ribosomes to produce proteins with a N-terminal fMet. These proteins are targeted for degradation by specific processes in the cell.
Codeine/paracetamol, also called codeine/acetaminophen and co-codamol, is a compound analgesic, comprising codeine phosphate and paracetamol (acetaminophen). Codeine/paracetamol is used for the relief of mild to moderate pain when paracetamol or non-steroidal anti-inflammatory drugs (NSAIDs; such as ibuprofen, aspirin, and naproxen) alone do not sufficiently relieve symptoms. In 2023, it was the 210th most commonly prescribed medication in the United States, with more than 2 million prescriptions.
Albumin-bound paclitaxel (brand name Abraxane, also called nab-paclitaxel) is an alternative formulation where paclitaxel is bound to albumin nanoparticles. Much of the clinical toxicity of paclitaxel is associated with the solvent Cremophor EL in which it is dissolved for delivery. Abraxis BioScience developed Abraxane, in which paclitaxel is bonded to albumin as an alternative delivery agent to the often toxic solvent delivery method. This was approved by the FDA in January 2005, for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within six months of adjuvant chemotherapy. It has since been approved for locally advanced or metastatic non-small cell lung cancer and metastatic adenocarcinoma of the pancreas as well. Taxanes, including paclitaxel, 10-deacetylbaccatin III, baccatin III, paclitaxel C, and 7-epipaclitaxel, have been found in the leaves and shells of hazel. The finding of these compounds in shells, which are considered discarded material and are mass-produced by many food industries, is of interest for the future availability of paclitaxel.
Lay the foundations to enable AI: securing world-class computing and data infrastructure, access to talent, and an appropriate regulatory environment. Key commitments include expanding the AI Research Resource (AIRR) by at least 20 times by 2030, establishing "AI Growth Zones" (AIGZs) to accelerate the build-out of AI data centres through streamlined planning and power provisioning, and developing a sovereign AI compute capability. Change lives by embracing AI: driving rapid AI adoption in the public sector, including in the National Health Service, education, and government administration, to improve public services and boost productivity. Secure our future with homegrown AI: positioning the UK as a partner of choice for frontier AI developers and building domestic AI companies that operate at multiple layers of the "AI stack", to ensure the UK benefits economically and has influence over the values and governance of future AI systems. The government projected that AI adoption could grow the UK economy by an additional £400 billion by 2030 and committed to a £2 billion investment in AI infrastructure. The UK government has proposed a plan to boost the country's AI infrastructure and expand its use in public services, with the UK Prime Minister Keir Starmer saying that the country would become one of the "AI superpowers".
Sources: en.wikipedia.org
=== Reaction to Harry Potter partnership === In August 2026, Tim Horton announced its “Back to Hogwarts with Harry Potter” campaign, with a series of themed products released to mark the 25th anniversary of the release of the first film of the Harry Potter movie franchise. The campaign received criticism from the 2SLGBTQ+ community, with Tim Horton being rebranded by online activists as "TERF-Hortons" for being perceived to be aligning themselves with J.K. Rowling's "anti-trans" views. Advocacy group Egale Canada argued that "as a brand that is synonymous with Canada, Tim Hortons and their partnerships should reflect Canada — a country that is inclusive and proud of its diversity".
Secretary of Defense Pete Hegseth said, "We devastated the Iranian nuclear program, but it's worth noting that the operation did not target Iranian troops or the Iranian people." On June 22, Trump said that since the Islamic regime in control of Iran has failed to make Iran great, it should be replaced to "Make Iran Great Again". Later, he posted on social media that their constant anger, hostility, and despair have only led them to ruin. The path they're on offers no hope, only more hardship, "I wish the leadership of Iran would realize that you often get more with honey than you do with vinegar".
Body pain, arthralgia, myalgia Chronic fatigue and insomnia Depression, anxiety and mood disorders Gastrointestinal complications such as constipation, diarrhea, and acid reflux Weight gain or loss Frequent infections
He also contributed greatly to the identification of vitamin B complex and was co-author of more than 780 scientific papers on biochemistry and nutrition. Elvehjem commented frequently on nutrition as it affects both scientist and layman. "Vitamins should be obtained from natural foods if possible", he cautioned. "Generally they are cheaper, more palatable, and in better balance with other factors when taken in this form." He acknowledged the value of synthetic vitamins in treating deficiency diseases, but warned that their use should be temporary. Elvehjem's first graduate student (in 1931) was noted nutritionist Fredrick John Stare (1910–2002) who later founded and chaired the department of nutrition at the Harvard School of Public Health, where he served until 1976. Elvehjem met his wife Constance W. Elvehjem when she was an undergraduate at UW Madison. She died in 1999 at the age of 94 after many years supporting the museum and the Madison community. Elvehjem was stricken with a heart attack at his desk on the morning of July 27, 1962, at the age of sixty-one and died within the hour.
In 1386, Grand Duke Jogaila of Lithuania converted to Catholicism and married Queen Jadwiga of Poland. This act enabled him to become a king of Poland himself, and he ruled as Władysław II Jagiełło until his death in 1434. The marriage established a personal Polish–Lithuanian union ruled by the Jagiellonian dynasty. The first in a series of formal "unions" was the Union of Krewo of 1385, whereby arrangements were made for the marriage of Jogaila and Jadwiga. The Polish–Lithuanian partnership brought vast areas of Ruthenia controlled by the Grand Duchy of Lithuania into Poland's sphere of influence and proved beneficial for the nationals of both countries, who coexisted and cooperated in one of the largest political entities in Europe for the next four centuries. When Queen Jadwiga died in 1399, the Kingdom of Poland fell to her husband's sole possession. In the Baltic Sea region, Poland's struggle with the Teutonic Knights continued and culminated in the Battle of Grunwald (1410), a great victory that the Poles and Lithuanians were unable to follow up with a decisive strike against the main seat of the Teutonic Order at Malbork Castle. The Union of Horodło of 1413 further defined the evolving relationship between the Kingdom of Poland and the Grand Duchy of Lithuania. The privileges of the szlachta (nobility) kept expanding and in 1425 the rule of Neminem captivabimus, which protected the noblemen from arbitrary royal arrests, was formulated.
Sources: en.wikipedia.org
Most states systems have ended in the universal empire, which has swallowed all the states of the system. The examples are so abundant that we must ask two questions: Is there any states system which has not led fairly directly to the establishment of a world empire? Does the evidence rather suggest that we should expect any states system to culminate in this way? …It might be argued that every state system can only maintain its existence on the balance of power, that the later is inherently unstable, and that sooner or later its tensions and conflicts will be resolved into a monopoly of power. Still earlier, Quincy Wright, concluded on the balance of power in world history:
Self-amplifying mRNA (saRNA) vaccines replicate their mRNA after transfection. Self-amplifying mRNA has two open reading frames. The first frame, like conventional mRNA, codes for the antigen of interest. The second frame codes for an RNA-dependent RNA polymerase (and its helper proteins) which replicates the mRNA construct in the cell. This allows smaller vaccine doses. The mechanisms and consequently the evaluation of self-amplifying mRNA may be different, as self-amplifying mRNA is a much bigger molecule. SaRNA vaccines being researched include a malaria vaccine. The first saRNA Covid vaccine authorised was Gemcovac, in India in June 2022. The second was ARCT-154, developed by Arcturus Therapeutics. A version manufactured by Meiji Seika Pharma was authorised in Japan in November 2023. GSK began a phase 1 trial of an saRNA COVID-19 vaccine in 2021. Gritstone bio started also started a phase 1 trial of an saRNA COVID-19 vaccine in 2021, used as a booster vaccine, with interim results published in 2023. The vaccine is designed to target both the spike protein of the SARS‑CoV‑2 virus, and viral proteins that may be less prone to genetic variation, to provide greater protection against SARS‑CoV‑2 variants. saRNA vaccines must use uridine, which is required for reproduction to occur.
An athletic contest in which the participants 'go queer' in their heads, and strain their powers until their faces become hideous with the tortures that rack them, is not sport, it is brutality. It appears from the reports of this singular performance that some of the bicycle riders have actually become temporarily insane during the contest... Days and weeks of recuperation will be needed to put the racers in condition, and it is likely that some of them will never recover from the strain. The father of anabolic steroids in the United States was John Ziegler (1917–1983), a physician for the U.S. weightlifting team in the mid-20th century. In 1954, on his tour to Vienna with his team for the world championship, Ziegler learned from his Russian colleague that the Soviet weightlifting team's success was due to their use of testosterone as a performance-enhancing drug. Deciding that U.S. athletes needed chemical assistance to remain competitive, Ziegler worked with the CIBA Pharmaceutical Company to develop an oral anabolic steroid. This resulted in the creation of methandrostenolone, which appeared on the market in 1960 under the brand name Dianabol. During the Olympics that year, the Danish cyclist Knud Enemark Jensen collapsed and died while competing in the 100-kilometer (62-mile) race. An autopsy later revealed the presence of amphetamines and a drug called nicotinyl tartrate in his system. The American specialist in doping, Max M.
Afterwards, the two leaders and their wives proceeded to the White House Rose Garden for a Military Review. The United States Air Force Honor Guard presenting American and Chinese flags were positioned upon the roof of West Wing Colonnade; BBC News observed it is "highly unusual to see uniformed soldiers standing at attention above the Oval Office" and remarked the welcome for Xi "has far exceeded the welcome given other visiting heads of state in Trump's second term". The 15‑minute presentation included the Old Guard Fife and Drum Corps dressed in Continental Army dress uniforms, the US Marine Corps Silent Drill Platoon and the United States Marine Drum and Bugle Corps performances with a flyover finale featuring a B-2 Spirit and four F-22 Raptors. Cai Qi, Wang Yi, JD Vance and his wife Usha Vance, and Ivanka Trump were also present at the ceremony. Afterwards, the two leaders and their respective contingents went to the Oval Office to start their meeting. which lasted for 90 minutes. Xi was accompanied by CCP General Office Director Cai Qi, Vice Premier He Lifeng, Central Foreign Affairs Commission Office Director and Foreign Minister Wang Yi, National Development and Reform Commission Director Zheng Shanjie, and Minister of Commerce Wang Wentao. Trump was joined by Vice President JD Vance, Secretary of State Marco Rubio, Secretary of Treasury Scott Bessent, White House Chief of Staff Susie Wiles and Secretary of Defense Pete Hegseth.
=== Photo-biomodulation therapy (PBMT) mechanism === Photobiomodulation therapy (PBMT) uses low-power densities and is characterized by its non-heat producing effects, a feature previously associated only with laser light. Nowadays, low-level LED lights offer a cost-effective alternative, expanding the accessibility and application of this therapeutic approach. PBMT (low-level light) targets mitochondria and has impacts on, 1) raising ROS levels, 2) creating adenosine triphosphate (ATP); and 3) helping to turn on transcription factor. That can trigger biochemical change within the cells, involve photon emitting light absorbed by the photoreceptor and cascade reaction. When exposed to LED light, the cytochrome c oxidase (CCO) inside the electron transport chain (ETC) of mitochondria is targeted. Its two heme and two copper subunits are oxidized or reduced, enabling it to absorb light at various wavelengths. CCO is the main target of near-infrared and red(650-1000 nm) wavelengths. Cytochrome c oxidase (CCO) is a key protein in the Electron Transport Chain, responsible for transferring electrons to the final oxygen acceptor. This action helps build a substantial proton gradient across the inter-membrane space of mitochondria; a process critical for the synthesis of ATP (Adenosine Triphosphate). The increased production of ATP because of this activity. CCO is also a photoreceptor, the photon absorption of CCO can lead to enhanced enzyme activity, increased oxygen consumption and usage of ATP production and the release of NO (nitric oxide).
Sources: en.wikipedia.org
It is registered as a pharmaceutical product in Russia, where it is typically supplied as a nasal solution. In most other countries it is not an approved drug and is traded as a research chemical instead. Approval status depends entirely on the jurisdiction involved.
Most published work uses intranasal administration, matching the route of the registered Russian formulation. Some animal experiments use intravenous or intraperitoneal injection. The route matters because the intact peptide is cleared rapidly from blood, so exposure differs between methods.
A purity value describes the share of the powder accounted for by the target peptide, usually by high-performance liquid chromatography. It does not confirm that the sequence is correct, which requires mass spectrometry or amino acid analysis. Purity and identity are separate checks.
Semax is a synthetic seven-amino-acid peptide derived from a fragment of corticotropin. It is used in Russia as a nasal preparation, while elsewhere it is studied as a research compound. It is not approved as a medicine in most countries.